Amid shortages of cancer drugs in the U.S., the API Innovation Center will use continuous manufacturing technology and a partnership with Apertus Pharmaceuticals and the Glioblastoma Foundation to ...
Enveda has been using AI to power its drug discovery platform for several years. The company injected $230 million into funding the process through June 2024. Meanwhile, Phlow grew its analytical ...
According to multiple recent market analyses, the global API market is experiencing steady growth. One comprehensive forecast projects the global active pharmaceutical ingredient market to expand from ...
The partnership combines Ginkgo's AI/ML and enzyme engineering expertise with Prozomix's wealth of enzyme sequence data to create best-in-class enzymes for API manufacturing This agreement also marks ...
Operating under the FDA's 503B pathway, the Apex facility will prioritize the production of generic shortage-listed ...
Saharsh Davuluri, Neuland Labs, urges API and peptide automation by 2026 to match modern biologics standards. PharmTech recently spoke with Saharsh Davuluri, Vice Chairman and Managing Director, ...